Afternoon Symposium


Real-world experiences with prolonged half-life rFVIIIFc in hemophilia A: New data and future prospects

Monday 22 June 12:15 –13:45
Chaired by Dr Manuel Carcao
Room 801, Level 800

2015-06-22 12:15:00 2015-06-22 13:45:00 America/Toronto ISTH Afternoon Symposium Real-world experiences with prolonged half-life rFVIIIFc in hemophilia A: New data and future prospects Room 801, Level 800 Dr Manuel Carcao, ISTH 2015


Dear Colleague,
I am delighted to invite you to join us at this afternoon symposium, where we will be sharing for the first time real-world data on the use of rFVIIIFc. Fc Fusion Factors are changing the management of hemophilia A, and the talks at this symposium will help you to better understand how you might be able to use these agents in your own practice. We look forward to seeing you.
Yours sincerely,
Manuel Carcao



AGENDA



12:15 Welcome Dr Wing Yen Wong, Biogen
Professor Stefan Lethagen, Sobi
12:20 Chair’s introduction: Today’s unmet needs and treatment goals: The patient perspective Dr Manuel Carcao (Chair), Canada
12:35 Real-world experience with Fc Fusion Factors in modern practice: The physician perspective Dr Guy Young, USA
13:00 Extended half-life factors: What do the new long-term data tell us? Professor Cedric Hermans, Belgium
13:15 Future prospects for hemophilia care: Exploring the emerging science Dr Richard Blumberg, USA
13:30 Panel discussion All
13:45 Chair’s summary and close Dr Manuel Carcao (Chair)



Speakers





Dr Manuel Carcao (Chair)

The Hospital for Sick Children in Toronto, Canada

Manuel D. Carcao is a staff paediatric haematologist/oncologist in the Division of Haematology/Oncology and an Associate Professor in the Dept of Paediatrics at The Hospital for Sick Children in Toronto. He is also Co-Director of the Comprehensive Ca...


Dr Wing Yen Wong

Biogen

Wing Yen Wong is Vice President of the Hematology/Immunology division of Global Medical at Biogen. Dr Wong joined Biogen in March of 2014 and leads the global medical strategies and activities in hemophilia, hemoglobinopathies, immunology and pulmon...


Professor Stefan Lethagen

Sobi

Stefan Lethagen is Vice President of Medical and Clinical Sciences, Haemophilia, at Swedish Orphan Biovitrum, Stockholm, Sweden. Stefan has been appointed Professor in Haemophilia and other Coagulation Disorders at Copenhagen University, Denmark, and...


Dr Guy Young

Children’s Hospital Los Angeles, USA | University of Southern California’s Keck School of Medicine, USA

Guy Young is the Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles and an Associate Professor of Pediatrics at the University of Southern California’s Keck School of Medicine.


Professor Cedric Hermans

Saint-Luc University Hospital of the Catholic University of Louvain, Belgium

Cedric Hermans is Head of the Division of Haemotology and the Haemostasis and Thrombosis Unit at Saint-Luc University Hospital of the Catholic University of Louvain, Brussels, Belgium. He was appointed Associate Professor at the Medical School of the...


Dr Richard Blumberg

Brigham and Women’s Hospital (BWH), USA

Richard S. Blumberg is currently Senior Physician in Medicine and Gastroenterology at Brigham and Women’s Hospital (BWH) where he leads the Division of Gastroenterology, Hepatology and Endoscopy, is Professor of Medicine at Harvard Medical School a...



Thanks for visiting us



Newsletter

Subscribe to our newsletter for updates on this symposium and to receive any post-event materials that may be available such as slides and videos.